Tivic Health Acquires Strategic Manufacturing And Development Assets Of Scorpius Holdings; Launches Velocity Bioworks Subsidiary; Secures $16M Debt, Up To $75M Preferred Equity, And $50M Credit Line from 3i, LP

Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity Bioworks™

Financing led by 3i, LP includes $16M debt financing for the purchase of assets and up to $75M in preferred convertible equity available for therapeutics commercialization and corporate growth initiatives

FREMONT, CA AND SAN ANTONIO, TX / ACCESS Newswire / December 11, 2025 / Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, today announced it has acquired the strategic manufacturing and development assets of Scorpius Holdings, Inc. and is launching Velocity Bioworks™, a wholly owned subsidiary of Tivic, to provide contract development and manufacturing services to Tivic and other companies.

Transaction Summary

Financing is led by 3i, LP and includes:

$16M debt financing for the purchase of assets, including equipment and facilities improvements

Up to $75M in preferred convertible equity, including $18M in two near-term tranches with the remainder available to the company at its discretion subject to certain conditions

In addition, an affiliate of 3i, LP is expected to provide the company with a $50M equity line of credit to further enhance access to growth capital.